BMS-Celgene 'biggest ever pharma merger'The takeover of Celgene by Bristol-Myers Squibb is the biggest ever merger in the pharmaceutical industry, according to M&A analysts, report FAZ (p. 22), Handelsblatt (p.1, 14-15 and 21), Sueddeutsche Zeitung (p.19) and Die Welt (p.9) on Friday (APMHE 61277).
CAR-T therapies a breakthroughCAR-T cell therapies mark a breakthrough for gene therapies, writes Handelsblatt in a 2018 review of game-changers in the industry on Friday (p.46).
NxStage's acquisition by Fresenius Medical Care delayedThe planned $2 billion acquisition of home dialysis equipment manufacturer NxStage Medical by Fresenius Medical Care (FMC) is delayed as the U.S. antitrust authority FTC has not yet given its decision, reported FAZ on Monday (p22).
Ablynx well established in BelgiumThe chief executive of Belgium biotech Ablynx Piet Houwen has praised the Ghent area as being "similar to Boston" in terms of an innovation-friendly environment, reported FAZ on Monday (p22).
Big pharma raising U.S. pricesPharmaceutical companies increased their prices in the U.S. by an average of 6.3% in January according to a study by RX Savings Solutions, Handelsblatt reported on Thursday (p17).
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.